Belharra Therapeutics
San Diego
About Belharra Therapeutics
Belharra Therapeutics is a privately held drug discovery company that is disrupting the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform. Belharra scientists can identify small molecule drug candidates for any binding site, on any protein, in any conformational state, and in any cell type using its chemoproteomics platform. Belharra is based in the San Francisco Bay Area, with its primary lab and offices in San Diego.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: belharratx.com
- Phone: (858) 800-4340
Industries & Categories
Biotechnology, Chemical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/belharra-therapeutics-41161 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.